Intrinsic Value
VYNE Therapeutics Inc. (VYNE)
$2.47
-0.10 (-3.89%)
| Enterprise Value | -51,408,879.58 |
|---|---|
| Net Debt | -30.46 |
| Equity Value | -51,408,849.12 |
| Shares Outstanding | 10.27 |
| Equity Value Per Share | -5,004,268.38 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt